GlassScriptPhysician profile
Kory R Lee
NPI 1861996738
$12,793.10
in general payments reported to CMS, 2019-2025
30 companies · $4,713 in 2025
The $4,713 reported for 2025 was more than what 89% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $115 · 2021: $14.06 · 2022: $976 · 2023: $3,806 · 2024: $3,035 · 2025: $4,713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $450 · Education: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,729.08 |
| Consulting Fee | $450.00 |
| Education | $375.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,030.65 | 2019-2025 | |
| Janssen Biotech, INC. | $1,328.08 | 2022-2025 | Tremfya |
| Genzyme Corporation | $1,198.44 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $986.63 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $912.77 | 2022-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $832.71 | 2022-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $752.13 | 2023-2025 | Zoryve |
| Leo Pharma INC. | $736.05 | 2022-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $592.99 | 2020-2025 | Taltz, Olumiant, Ebglyss |
| Pfizer INC. | $474.41 | 2022-2025 | |
| Incyte Corporation | $431.50 | 2022-2025 | Opzelura |
| Amgen INC. | $422.62 | 2021-2025 | Otezla, Otezla |
| Ucb, INC. | $331.54 | 2022-2025 | Bimzelx, Cimzia |
| Mayne Pharma Commercial LLC | $265.13 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $249.53 | 2023-2025 | Winlevi, Absorica Ld, Ilumya |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $242.70 | 2022-2025 | Nemluvio, Aklief, Oracea |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $199.62 | 2022-2025 | Cabtreo, Jublia, Siliq |
| Verrica Pharmaceuticals INC. | $177.47 | 2023 | Ycanth |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.81 | 2025 | Spevigo |
| Epi Health, LLC | $93.81 | 2022 | |
| Almirall LLC | $92.22 | 2022-2025 | Seysara |
| Celgene Corporation | $90.92 | 2019 | |
| Dermavant Sciences, INC. | $50.64 | 2023 | Vtama |
| Journey Medical Corporation | $44.25 | 2022-2025 | |
| Elekta, INC. | $40.22 | 2024 | Elekta Medical Linear Accelerator |
| Springworks Therapeutics, INC. | $25.88 | 2025 | Gomekli |
| Organon LLC | $23.50 | 2025 | |
| Biofrontera INC. | $18.39 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Botanix Sb INC | $16.46 | 2025 | Sofdra |
| Mallinckrodt Hospital Products INC. | $14.03 | 2025 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kory Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.